Emami Limited
4,959words
67turns
5analyst exchanges
7executives
Management on call
Mohan Goenka
VICE CHAIRMAN AND
Vivek Dhir
CHIEF EXECUTIVE OFFICER
Gul Raj Bhatia
PRESIDENT (HEALTHCARE), EMAMI LIMITED
Manish Gupta
PRESIDENT (SALES), EMAMI LIMITED
Giriraj Bagri
CHIEF GROWTH OFFICER, EMAMI LIMITED
Rajesh Sharma
PRESIDENT (FINANCE &
Percy Panthaki
IIFL CAPITAL
Key numbers — 40 extracted
11%
7%
16%
27%
13%
1%
12%
9%
5%
50%
80%
28%
Advertisement
Guidance — 14 items
Mohan Goenka
opening
“We are sharpening Kesh King strategy on solving for both medium term strategic issues as well as tactical challenges, E-com pricing SKU mix and media effectiveness.”
Mohan Goenka
opening
“With strategic actions being taken for male grooming, range Kesh King and The Man Company, we anticipate positive momentum for these brands in FY ‘26.”
Mohan Goenka
opening
“We expect a gradual pickup in consumption, supported by easing inflation, recent income tax benefits to individual taxpayers, higher government CAPEX and a more accommodative monetary policy, including potential rate cuts.”
Abhneesh Roy
qa
“My first question is on Zairus Master, so here my question is, what will be his key KRA from the next two to three years’ perspective?”
Abhneesh Roy
qa
“So what will be his main target over the next two to three years’ timeframe in Man Company?”
Mohan Goenka
qa
“So, of course, the target is to get back to growth, to take The Man Company and other startups on the fast track, how can we get to substantial growth.”
Mohan Goenka
qa
“I am not expecting profits immediately, but of course the long term target is to get these brands to profitability.”
Giriraj Bagri
qa
“So I expect a very significant rebound to happen in The Man Company in the months to come.”
Gul Raj Bhatia
qa
“Going forward, we are going to drive improved marketing campaigns, focusing on a better return on investment, considering the fact that consumer shifts are also happening.”
Gul Raj Bhatia
qa
“So, we will also be focused on NPDs, but I think the focus will be compared to previous years more on consolidating and leveraging the NPDs we launch to see how we are able to scale them up in a profitable manner.”
Risks & concerns — 12 flagged
After absorbing the revenue decline of 12% in our strategic investment portfolio, our overall domestic business grew by 9% in Q4 with a volume growth of about 5%.
— Mohan Goenka
Turning to our international business, after the decline in Q3, we returned to growth in Q4, posting a 6% increase despite geopolitical and macroeconomic challenges in Bangladesh, Middle East, and some parts of Africa.
— Mohan Goenka
In Man Company, in the past few quarters, your stake has almost become 100% and the numbers have been a bit volatile.
— Abhneesh Roy
So in terms of now this new leadership and the overall performance has been a bit volatile.
— Abhneesh Roy
And in terms of anything weak in the business model, is there something weak or is it just the demand scenario which was weak, and the transition was there?
— Abhneesh Roy
So there would be slight challenge on our summer portfolio, and we will try to see if we can make it up with some of our other portfolios.
— Mohan Goenka
I think the audio quality at the end was weak, but I got the gist.
— Abhneesh Roy
Ultra Power and Mentho Plus has consistently been growing, but unfortunately the green pack, which is the main product, is showing signs of some stress.
— Mohan Goenka
Smart and Handsome, the decline has been arrested.
— Mohan Goenka
But having said that, mid singles should not be a problem, repeating the base is always tough, that's the current challenge we are having internally, oil so far looks robust.
— Manish Gupta
And I have continuously been maintaining that I do not see any pressure on our GCs this year also.
— Giriraj Bagri
Then we do not see any pressure on margins.
— Giriraj Bagri
Advertisement
Q&A — 5 exchanges
Speaking time
20
10
7
7
5
4
4
4
3
1
Advertisement
Opening remarks
Percy Panthaki
Hi, good evening. Welcome everyone. I have with me the Management of Emami. I have Mr. Mohan Goenka – Whole-Time Director and Vice Chairman; Mr. Vivek Dhir – CEO (International Business); Mr. Gul Raj Bhatia – President (Healthcare Business); Mr. Manish Gupta – President (Sales), and Mr. Giriraj Bagri – Chief Growth Officer; Mr. Rajesh Sharma – President (Finance & IR). Without further ado, I will hand over the call to the Management who will take you through the results and then we will have the Q&A. Over to you, sir.
Mohan Goenka
Thank you, Percy. Very good afternoon, ladies, and gentlemen. Thank you for taking this time to join us today for our Earnings Call for the 4th Quarter and the Financial Year ended 31st March, ‘25. Consumption demand trends in Q4 remained similar to the previous quarter. While rural markets continued to perform well, mass urban demand remains subdued. In this scenario, I am pleased to report that our core domestic business continued to deliver robust growth this quarter also, this time growing by double digit at 11%, with volume growth of around 7%. This growth was achieved across brands and categories, reflecting strong well-rounded performance throughout the portfolio. Navratna and Dermicool range grew by 16%. BoroPlus range delivered growth of 27%. Healthcare range grew by 13%. And pain management grew by 1%. In the male grooming category, our recent rebranding efforts are showing early success. The newly repositioned Smart and Handsome brand posted a 7% growth, and Kesh King delive
Advertisement